期刊文献+

Exendin-4对小鼠巨噬细胞一氧化氮生成和促炎/抗炎反应平衡的影响 被引量:1

Effects of exendin-4 on production of nitric oxide and promotion of IL-10/IL-12 balance in macrophages
下载PDF
导出
摘要 目的:探讨新型糖尿病药物exendin-4(Ex-4)影响小鼠巨噬细胞一氧化氮(NO)生成和IL-10/IL-12分泌的量效-时效关系,以及是否经由PI3K/Akt/mTOR信号转导通路产生该作用。方法:体外培养小鼠RAW264.7巨噬细胞株,在有或者无细菌脂多糖(LPS)诱导下,给予不同浓度的Ex-4(1、10、50 nmol/L)刺激,并在培养4、8和24 h收集上清,分别采用Griess和ELISA方法检测上清NO和IL-10/IL-12的分泌水平。此外,分别给予mTOR抑制剂雷帕霉素或PI3K抑制剂LY294002预处理巨噬细胞1 h,再给予低、中浓度Ex-4(1、10 nmol/L)刺激,观察巨噬细胞NO的产生和IL-10/IL-12的分泌是否发生改变。结果:无论是否存在LPS,Ex-4均能显著促进小鼠RAW264.7细胞分泌IL-10,同时抑制IL-12和NO的分泌,并且星明显的时效-量效关系,中浓度Ex-4已达最大效应(与低浓度比较,P<0.05;与高浓度比较,P>0.05),该作用能被LY294002和雷帕霉素逆转(P<0.05或P<0.01),尤以雷帕霉素最为显著。结论:Ex-4可通过PI3K/Akt/mTOR信号通路调控单核细胞NO的分泌,并影响IL-10/IL-12的平衡,可能是其参与免疫调节的机制之一。 Objective: To investigate the dose-and time-dependent effects of exendin-4 on the production of nitric oxide (NO) and IL-10/IL-12 balance in maerophage, and to ascertain whether the phosphatidylinositol 3-kinase/ protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is involved. Methods: Murine macrophage RAW264.7 cell line was treated with different doses of exendin-4 (1,10,50 nmol/L) for 4, 8 or 24 hours with or without lipopolysaceharide (LPS). In another set of experiment, RAW264.7 maerophage was cultured with low (1 nmol/L)or medium (10 nmol/L) dose of Ex-4 after 1-hour pretreatment with PI3K inhibitor (LY294002) or prototypic mTOR inhibitor (Rapamycin) for 4 hours. Cell-free supernatants were harvested for NO and IL-10/IL-12 assessment with Griess reagent and ELISA, respectively. Results: Compared with control group, exendin-4 could significantly increase the production of IL-10 while inhibit the secretion of NO and IL-12 with or without LPS in a dose-and time-dependent manner, and a medium dose of gx-4 exerted the most significant effect (P〈0.05 compared to low dose of Ex-4 but P〈0.05 compared to high-dose of Ex-4). LY294002 and Rapamycin, the two PI3K/Akt/mTOR inhibitors, had the potential to reverse the effect of exendin-4 (P〈0. 05 or P〈0.01), and between them, rapamycin was more effective. Conclusions:Exendin-4 might regulate, at least in part, the secretion of NO and IL-10/IL-12 balance in maerophage via PI3K/Akt/mTOR pathway, contributing to immune regulation.
出处 《感染.炎症.修复》 2013年第4期201-206,共6页 Infection Inflammation Repair
基金 国家自然科学基金项且(30973120 81272089 81372054) 国家重点基础研究发展计划项目(2012CB518102) 军队"十二五"医药卫生科研基金重点项目(BWS12J050)
关键词 脓毒症 EXENDIN-4 一氧化氮 白细胞介素10 白细胞介素12 磷脂酰肌醇激酶3 哺乳动物雷帕霉素靶蛋白 Sepsis Exendin-4 Nitric oxide Interleukin-10 Interleukin -12 Phosphatidylinositol 3-kinase Mammalian target of rapamycin
  • 相关文献

参考文献14

  • 1Wu HP,Shih CC,Lin CY,et al.Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors.Crit Care,2011,15:R224.
  • 2董宁,姚咏明,于燕,盛志勇.重组BPI对内毒素休克大鼠肝脏一氧化氮合酶和微循环灌注的影响[J].感染.炎症.修复,2000,1(2):102-102. 被引量:1
  • 3Fukao T,Tanabe M,Terauchi Y,et al.PI3K-mediated negative feedback regulation of IL-12 production in DCs.Nat Immunol,2002,3:875-881.
  • 4Sherry NA,Chen W,Kushner JA,et al.Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.Endocrinology,2007,148:5136-5144.
  • 5Van de Velde S,Hogan MF,Montminy M.mTOR links incretin signaling to HIF induction in pancreatic beta cells.Proc Natl Acad Sci USA,2011,108:16876-16882.
  • 6Kelly-Scumpia KM,Scumpia PO,Weinstein JS,et al.B cells enhance early innate immune responses during bacterial sepsis.J Exp Med,2011,208:1673-1682.
  • 7Lange M,Connelly R,Traber DL,et al.Time course of nitric oxide synthases,nitrosative stress,and poly (ADP ribosylation) in an ovine sepsis model.Crit Care,2010,14:R129.
  • 8Favaro E,Granata R,Miceli I,et al.The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions,through phosphoinositide 3-kinase/Akt,extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.Diabetologia,2012,55:1058-1070.
  • 9Arakawa M,Mita T,Azuma K,et al.Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist,exendin-4.Diabetes,2010,59:1030-1037.
  • 10Fielhaber JA,Carroll SF,Dydensborg AB,et al.Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis.J Immunol,2012,188:4535-4542.

二级参考文献11

  • 1朱海云,郑贵军,李银平,姚咏明.血必净注射液对脓毒症大鼠低氧诱导因子-1α及其靶基因诱导型一氧化氮合酶表达的影响[J].中国中西医结合急救杂志,2010,17(2):96-98. 被引量:11
  • 2张淑文,孙成栋,文艳,阴赪宏.血必净注射液对脓毒症大鼠血清炎症介质及Th1/2的影响[J].中国危重病急救医学,2006,18(11):673-676. 被引量:110
  • 3Kelly-Scumpia KM, Scumpia PO,Weinstein JS? etal. B cells en-hance early innate immune responses during bacterial sepsis. JExp Med, 2010,208(8):1673-1682.
  • 4Fielhaber JA, Carroll SF,Dydensborg AB* et al. Inhibition of mam-malian target of rapamycin augments lipopolysaccharide-induced lunginjury and apoptosis. J Immunol, 2012,188(9) :4535-4542.
  • 5Matthias L, Rhykka C, Daniel LT, et al. Time course of nitricoxide synthases, nitrosative stress, and poly (ADP ribosylation)in an ovine sepsis model. Crit Care, 2010,14(4) :1-10.
  • 6Muenzer JT, Davis CG, Chang K, et al. Characterization andmodulation of the immunosuppressive phase of sepsis. Infect Im-mun, 2010, 78(4):1582-1592.
  • 7Hotchkiss RS,Coopersmith CM, McDunn JE, ei al. Tilting to-ward immunosuppression. Nat Med, 2009, 15(4) :496-497.
  • 8Weichhart T, Saemann MD. The PI3K/Akt/mTOR pathway ininnate immune cells : emerging therapeutic applications. AnnRheum Dis, 2008,67(3):370-374.
  • 9Weichhart T,Haidinger M, Katholnig K,et al. Inhibition ofmTOR blocks the anti-inflammatory effects of glucocorticoids inmyeloid immune cells. Blood,2011,117(16):4273-4283.
  • 10Boomer JS? To K, Chang KC?ei al. Immunosuppression in pa-tients who die of sepsis and multiple organ failure. JAMA,2011, 306(23):2594-2605.

共引文献5

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部